Legacy Trust’s Verrica Pharmaceuticals VRCA Stock Holding History

Legacy Trust’s Portfolio VRCA Stock Details VRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$101K	Sell	16,584 -650	-4%	-$4.05K	0.02%	209
2026 Q1	$91.2K	Hold	17,234	–	–	0.02%	202
2025 Q4	$143K	Buy	+17,234	New	+$95.5K	0.03%	191
2025 Q3	–	Sell	-650	Closed	-$3.45K	–	190
2025 Q2	$3.45K	Hold	650	–	–	﹤0.01%	144
2025 Q1	$2.87K	Hold	650	–	–	﹤0.01%	159
2024 Q4	$4.55K	Buy	+650	New	+$7.14K	﹤0.01%	157
2024 Q2	–	Sell	-1,875	Closed	-$111K	–	150
2024 Q1	$111K	Hold	1,875	–	–	0.03%	149
2023 Q4	$137K	Hold	1,875	–	–	0.04%	155
2023 Q3	$72.8K	Hold	1,875	–	–	0.02%	156
2023 Q2	$108K	Hold	1,875	–	–	0.03%	161
2023 Q1	$122K	Buy	+1,875	New	+$113K	0.04%	157

Other funds holding VRCA

APW

Allied Private Wealth Boca Raton, Florida $156M AUM

NECFA

New England Capital Financial Advisors Meriden, Connecticut $418M AUM 16.7% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

VNA

Valley National Advisers Bethlehem, Pennsylvania $900M AUM 31.19% 1-Year Est. Return

Legacy Trust's VRCA Position: Q2 2026 in Review

Legacy Trust reduced its Verrica Pharmaceuticals (VRCA) stake by 3.8% in Q2 2026, selling an estimated $4.05K and leaving 16,584 shares worth $101K. The position accounts for 0.02% of the portfolio, ranked #209.

Legacy Trust first reported a position in VRCA in Q1 2023 and has held it in 11 quarters since. The position peaked at $143K in Q4 2025. 6 funds tracked by Wall St. Rank hold VRCA as of Q2 2026.

Legacy Trust held 16,584 shares of Verrica Pharmaceuticals worth $101K as of Q2 2026.
Legacy Trust sold 650 Verrica Pharmaceuticals shares in Q2 2026, an estimated $4.05K.
Verrica Pharmaceuticals made up 0.02% of Legacy Trust's portfolio in Q2 2026, its #209 holding.
Legacy Trust first reported a position in Verrica Pharmaceuticals in Q1 2023 and has held it in 11 quarters since.
Legacy Trust's Verrica Pharmaceuticals position peaked at $143K in Q4 2025.
6 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2026.

Based on Legacy Trust's 13F filing for Q2 2026, filed 31 Jul 2026.